PubMed:34047722 / 1234-1409 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T19","span":{"begin":0,"end":175},"obj":"Sentence"},{"id":"T19","span":{"begin":0,"end":175},"obj":"Sentence"}],"text":"There was significantly lower all-cause 28-day mortality in EDGT with ScvO2 than without ScvO2 group [37.3% vs. 57.5%, adjusted hazard ratio 0.57, 95%CI 0.33 to 0.97, P=0.04]."}